Inventor
WU CHENGBIN
CN24 patents
⚠️ This page may combine multiple inventors who share the name “WU CHENGBIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
10 patentsUS9447184B2Sep 20, 2016
IL-1 binding proteins
ABBVIE INC27 citations94
US8383778B2Feb 26, 2013
IL-1 binding proteins
ABBVIE INC42 citations94
US9592293B2Mar 14, 2017
Interleukin-13 binding proteins
ABBVIE INC18 citations92
US8664367B2Mar 4, 2014
IL-I binding proteins
ABBVIE INC16 citations92
US9447183B2Sep 20, 2016
IL-1 binding proteins
ABBVIE INC9 citations84
US9441038B2Sep 13, 2016
IL-1 binding proteins
ABBVIE INC4 citations84
US9409986B2Aug 9, 2016
IL-1 binding proteins
ABBVIE INC6 citations84
US10086076B2Oct 2, 2018
Interleukin-13 binding proteins
ABBVIE INC4 citations83
US11344621B2May 31, 2022
Interleukin-13 binding proteins
ABBVIE INC2 citations72
US9303085B2Apr 5, 2016
IL-1 binding proteins
ABBVIE INC2 citations63
WU CHENGBIN
5 patentsUS8258268B2Sep 4, 2012
Dual variable domain immunoglobulin and uses thereof
WU CHENGBIN285 citations98
US8853365B2Oct 7, 2014
Dual variable domain immunnoglobulins and uses thereof
WU CHENGBIN27 citations92
US8841417B2Sep 23, 2014
IL-1 binding proteins
WU CHENGBIN22 citations92
US8398966B2Mar 19, 2013
IL-1 binding proteins
WU CHENGBIN35 citations92
US8604177B2Dec 10, 2013
Interleukin-13 binding proteins
WU CHENGBIN3 citations61
EPIMAB BIOTHERAPEUTICS INC
3 patentsUS10266608B2Apr 23, 2019
Fabs-in-tandem immunoglobulin and uses thereof
EPIMAB BIOTHERAPEUTICS INC23 citations93
US11421028B2Aug 23, 2022
Fabs-in-tandem immunoglobulin and uses thereof
EPIMAB BIOTHERAPEUTICS INC3 citations71
US12540185B2Feb 3, 2026
Fabs-in-tandem immunoglobulin and uses thereof
EPIMAB BIOTHERAPEUTICS INC0 citations61